Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease

Intestinal B-cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling

(2023) Elena Kotsiliti et al.   JOURNAL OF HEPATOLOGY

Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective

(2023) Lijun Luo et al.   LIFE SCIENCES

Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease

(2023) Jiandong Yang et al.   Communications Biology

Exploring the landscape of steatotic liver disease in the general US population

(2023) Stefano Ciardullo et al.   LIVER INTERNATIONAL

Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A

(2022) Takashi Owaki et al.   Disease Models & Mechanisms

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver

(2021) Masayoshi Ko et al.   Disease Models & Mechanisms

Mice with gene alterations in the GH and IGF family

(2021) Yanrong Qian et al.   Pituitary

Liver tissue microbiome in NAFLD: next step in understanding the gut–liver axis?

(2020) Herbert Tilg et al.   GUT

Ghrelin‐insulin‐like growth factor‐1 axis is activated via autonomic neural circuits in the non‐alcoholic fatty liver disease

(2020) Takuro Nagoya et al.   NEUROGASTROENTEROLOGY AND MOTILITY

The liver–brain–gut neural arc maintains the Treg cell niche in the gut

(2020) Toshiaki Teratani et al.   NATURE

The melanocortin pathway and control of appetite-progress and therapeutic implications

(2019) Giulia Baldini et al.   JOURNAL OF ENDOCRINOLOGY

Effect of a neural relay on liver regeneration in mice: activation of serotonin release from the gastrointestinal tract

(2018) Ryosuke Inoue et al.   FEBS Open Bio

Targeting the gut-liver axis in liver disease

(2017) Reiner Wiest et al.   JOURNAL OF HEPATOLOGY

Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol

(2016) Khalidur Rahman et al.   GASTROENTEROLOGY

IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner

(2016) Hitoshi Nishizawa et al.   Scientific Reports

The insulin-like growth factor I system: Physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome

(2015) Jun Ren et al.   BIOCHEMICAL PHARMACOLOGY

Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame

(2015) Samar H. Ibrahim et al.   DIGESTIVE DISEASES AND SCIENCES

Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency

(2014) Ryusaku Matsumoto et al.   GROWTH HORMONE & IGF RESEARCH

Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease

(2014) Yoshio Sumida et al.   HEPATOLOGY RESEARCH

Neural melanocortin receptors in obesity and related metabolic disorders

(2013) Clemence Girardet et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver [Review]

(2012) Yutaka Takahashi   ENDOCRINE JOURNAL

Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy

(2012) H. Nishizawa et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus

(2012) F. D. Jeanneteau et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Nonalcoholic Steatohepatitis

(2011) Michiko Itoh et al.   AMERICAN JOURNAL OF PATHOLOGY

Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels

(2011) Alessandra Fusco et al.   CLINICAL ENDOCRINOLOGY

Nonalcoholic Fatty Liver Disease Is Associated with Low Circulating Levels of Insulin-Like Growth Factor-I

(2011) Franco Arturi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IGF-I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats

(2009) Luciano Sobrevals et al.   HEPATOLOGY